Code of Maryland Regulations › Title 09 - MARYLAND DEPARTMENT OF LABOR › Subtitle 10 - RACING COMMISSION › Chapter 09.10.03 - Prohibited Acts › Section 09.10.03.01-1 - Restricted Use of Medications and Other Substances

Current through Register Vol. 51, No. 14, July 12, 2024
The use of the following medications and other substances is
				  permitted if quantitated at not more than the specified thresholds:
A. Acepromazine quantitated at not more than
				10 nanograms per milliliter of HEPS in urine;
B. Albuterol quantitated at not more than 1
				nanogram per milliliter of urine;
C. Butorphanol quantitated at not more than
				300 nanograms per milliliter of total butorphanol in urine, or 2 nanograms per
				milliliter of free butorphanol in blood plasma or serum;
D. Caffeine quantitated at not more than 100
				nanograms per milliliter of blood plasma or serum;
E. Cetirizine quantitated at not more than 6
				nanograms per milliliter of blood plasma or serum;
F. Cimetidine quantitated at not more than
				400 nanograms per milliliter of blood plasma or serum;
G. Cobalt quantitated at not more than 25
				nanograms per milliliter of blood plasma or serum;
H. Dantrolene qunatitated at not more than
				100 picrograms per milliliter of 5-hydroxydantrolene in blood plasma or
				serum;
I. Detomidine quantitated at
				not more than 2 nanograms per milliliter of carboxydetomidine in urine, or 1
				nanogram of detomidine per milliliter o/blood plasma or serum;
J. Dimethlysulfoxide (DMSO) quantitated at
				not more than 10 micrograms per milliliter of blood plasma or serum;
K. Flunixin quantitated at not more than 5
				nanograms per milliliter of blood plasma or serum;
L. Furosemide (Lasix), as provided in
				Regulation .08 of this chapter;
M.
				Gamma aminobutyric acid quantitated at not more than 110 nanograms per
				milliliter of blood plasma or serum;
N. Glycopyrrolate quantitated at not more
				than 3 picograms per milliliter of blood plasma or serum;
O. Guaifenesin quantitated at not more than
				12 nanograms per milliliter of blood plasma or serum;
P. Ketoprofen quantitated at not more than 2
				nanograms per milliliter of blood plasma or serum;
Q. Lidocaine quantitated at not more than 20
				picograms per milliliter of total 3-hydroxylidocaine in blood plasma or
				serum;
R. Mepivacaine quantitated
				at not more than 10 nanograms per milliliter of total hydroxymepivacaine in
				urine, or the limit of detection of mepivacaine in blood plasma or
				serum;
S. Methocarbamol quantitated
				at not more than 1 nanogram per milliliter of blood plasma or serum;
T. Methylprednisone quantitated at not more
				than 100 picograms per milliliter of blood plasma or serum;
U. Omeprazole quantitated at not more than 10
				nanograms per milliliter of blood plasma or serum;
V. Phenylbutazone quantitated at not more than 0.3
				micrograms per milliliter of the blood plasma or serum;
W. Procaine Penicillin quantitated at not
				more than 25 nanograms per milliliter of blood plasma or serum;
X. Ranitidine quantitated at not more than 40
				nanograms per milliliter of blood plasma or serum;
Y. Xylazine quantitated at not more than 200
				picigrams per milliliter of blood plasma or serum;
Z. Nandrolone quantitated at not more than 1
				nanogram per milliliter of urine taken from a gelding, filly, or
				mare;
AA. Boldenone quantitated at
				not more than 15 nanograms per milliliter of urine taken from a colt or
				horse;
BB. Testosterone quantitated
				at not more than 20 nanograms per milliliter of urine taken from a gelding;
				and
CC. Testosterone quantitated at
				not more than 55 nanograms per milliliter of urine taken from a filly or
				mare.